Hill-Rom Holdings, Inc. (HRC) Shares Sold by Canada Pension Plan Investment Board

Canada Pension Plan Investment Board trimmed its stake in Hill-Rom Holdings, Inc. (NYSE:HRC) by 55.7% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 7,400 shares of the medical technology company’s stock after selling 9,300 shares during the quarter. Canada Pension Plan Investment Board’s holdings in Hill-Rom were worth $548,000 at the end of the most recent quarter.

A number of other institutional investors also recently added to or reduced their stakes in HRC. State Street Corp raised its stake in shares of Hill-Rom by 2.7% in the second quarter. State Street Corp now owns 1,681,107 shares of the medical technology company’s stock worth $133,831,000 after purchasing an additional 43,645 shares during the last quarter. Amalgamated Bank increased its position in Hill-Rom by 25.7% during the second quarter. Amalgamated Bank now owns 13,108 shares of the medical technology company’s stock valued at $1,044,000 after acquiring an additional 2,678 shares during the last quarter. American Century Companies Inc. increased its position in Hill-Rom by 1,191.1% during the second quarter. American Century Companies Inc. now owns 110,359 shares of the medical technology company’s stock valued at $8,786,000 after acquiring an additional 101,811 shares during the last quarter. Brookstone Capital Management purchased a new stake in Hill-Rom during the second quarter valued at $289,000. Finally, Fred Alger Management Inc. grew its holdings in Hill-Rom by 163.3% during the second quarter. Fred Alger Management Inc. now owns 9,217 shares of the medical technology company’s stock valued at $734,000 after purchasing an additional 5,717 shares during the period. 82.35% of the stock is currently owned by institutional investors and hedge funds.

Shares of Hill-Rom Holdings, Inc. (HRC) traded up $0.20 during mid-day trading on Thursday, reaching $83.44. The company’s stock had a trading volume of 268,329 shares, compared to its average volume of 503,729. Hill-Rom Holdings, Inc. has a fifty-two week low of $54.59 and a fifty-two week high of $85.25. The company has a debt-to-equity ratio of 1.55, a quick ratio of 1.34 and a current ratio of 1.77. The stock has a market capitalization of $5,474.99, a P/E ratio of 21.55, a PEG ratio of 1.77 and a beta of 1.19.

Hill-Rom (NYSE:HRC) last issued its quarterly earnings results on Friday, November 3rd. The medical technology company reported $1.32 earnings per share for the quarter, topping the consensus estimate of $1.27 by $0.05. The firm had revenue of $738.30 million for the quarter, compared to the consensus estimate of $731.10 million. Hill-Rom had a return on equity of 20.27% and a net margin of 4.87%. The company’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same period in the prior year, the business posted $1.18 earnings per share. equities research analysts expect that Hill-Rom Holdings, Inc. will post 4.26 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 29th. Shareholders of record on Friday, December 15th will be issued a dividend of $0.18 per share. The ex-dividend date is Thursday, December 14th. This represents a $0.72 annualized dividend and a yield of 0.86%. Hill-Rom’s payout ratio is currently 36.18%.

Several research firms have issued reports on HRC. ValuEngine lowered Hill-Rom from a “buy” rating to a “hold” rating in a report on Friday, December 1st. Stifel Nicolaus reaffirmed a “buy” rating and issued a $92.00 price objective on shares of Hill-Rom in a research note on Wednesday, November 29th. Bank of America reaffirmed a “hold” rating on shares of Hill-Rom in a research note on Wednesday, November 22nd. Zacks Investment Research lowered Hill-Rom from a “buy” rating to a “hold” rating in a research note on Tuesday, November 7th. Finally, Barclays increased their price target on Hill-Rom from $86.00 to $90.00 and gave the company an “overweight” rating in a research note on Monday, November 6th. Five equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average target price of $89.57.

In other Hill-Rom news, SVP Andreas G. Frank sold 3,940 shares of the firm’s stock in a transaction on Wednesday, September 13th. The stock was sold at an average price of $77.84, for a total transaction of $306,689.60. Following the transaction, the senior vice president now directly owns 16,701 shares in the company, valued at approximately $1,300,005.84. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Andreas G. Frank sold 6,870 shares of the stock in a transaction on Thursday, September 14th. The shares were sold at an average price of $77.48, for a total value of $532,287.60. Following the sale, the senior vice president now directly owns 16,701 shares in the company, valued at approximately $1,293,993.48. The disclosure for this sale can be found here. Company insiders own 2.20% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Hill-Rom Holdings, Inc. (HRC) Shares Sold by Canada Pension Plan Investment Board” was originally reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece on another publication, it was illegally copied and republished in violation of U.S. & international trademark and copyright laws. The original version of this piece can be viewed at https://www.dispatchtribunal.com/2017/12/07/canada-pension-plan-investment-board-sells-9300-shares-of-hill-rom-holdings-inc-hrc.html.

About Hill-Rom

Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.

Institutional Ownership by Quarter for Hill-Rom (NYSE:HRC)

Receive News & Ratings for Hill-Rom Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply